Refine
Year of publication
- 2018 (40) (remove)
Document Type
- Article (22)
- Conference Proceeding (11)
- Part of a Book (6)
- Book (1)
Keywords
- Antarctica (1)
- Bladder (1)
- Dry surfaces (1)
- GOSSAMER-1 (1)
- Growth modelling (1)
- Jupiter (1)
- MASCOT (1)
- Mars (1)
- Mechanical simulation (1)
- Microbial adhesion (1)
- Muscle fibers (1)
- Passive stretching (1)
- Pelvic floor dysfunction (1)
- Pelvic muscle (1)
- Planetary exploration (1)
- Reconstruction (1)
- Rehabilitation Technology and Prosthetics (1)
- Sampling methods (1)
- Surface microorganisms (1)
- Surgical Navigation and Robotics (1)
- Swabbing (1)
- Ureter (1)
- achilles tendon (1)
- energy absorption (1)
- energy dissipation (1)
- habitability (1)
- ice moons (1)
- icy moons (1)
- life detection (1)
- mechanical buffer (1)
- multiple NEA rendezvous (1)
- small spacecraft (1)
- solar sail (1)
- space missions (1)
- stiffness (1)
- underwater vehicle (1)
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CM) today are widely used for the investigation of normal electromechanical cardiac function, of cardiac medication and of mutations. Computational models are thus established that simulate the behavior of this kind of cells. This section first motivates the modeling of hiPS-CM and then presents and discusses several modeling approaches of microscopic and macroscopic constituents of human-induced pluripotent stem cell-derived and mature human cardiac tissue. The focus is led on the mapping of the computational results one can achieve with these models onto mature human cardiomyocyte models, the latter being the real matter of interest. Model adaptivity is the key feature that is discussed because it opens the way for modeling various biological effects like biological variability, medication, mutation and phenotypical expression. We compare the computational with experimental results with respect to normal cardiac function and with respect to inotropic and chronotropic drug effects. The section closes with a discussion on the status quo of the specificity of computational models and on what challenges have to be solved to reach patient-specificity.